BIO-GENE TECHNOLOGY LTD

*Disclaimer

BIO-GENE TECHNOLOGY LTD (ASX: BGT)

🔗 📄 📈

BGT: GRDC Confirms Support for Flavocide in Grain Storage

BIO-GENE TECHNOLOGY LTD

Grains Research & Development Corporation (GRDC) supports the continued development and registration of Flavocide™ for use in grain storage.
The collaborative project between GRDC, Bio-Gene, BASF, and QDAF ended in 2022, confirming Flavocide's efficacy in controlling grain storage pests.
GRDC encourages Bio-Gene to engage with potential partners for the commercialization of Flavocide as a stored grain protectant.

2023-05-11 10:26:00

BGT: Synergy Studies Offer Significant Commercial Opportunities

BIO-GENE TECHNOLOGY LTD

Independent research confirms significant synergy results for both Flavocide and Qcide when used in combination with other commercially important insecticides.
Combining Flavocide and Qcide with other insecticides reduces application rates, lowers costs, and increases the ability to tackle resistance, providing commercial value to the global insecticide industry.
Synergy tests were conducted by globally recognized research organizations and have attracted interest from global companies, resulting in the signing of a new Material Transfer Agreement for commercial synergy opportunities.

2023-04-26 08:57:00

BGT: Board and Management Changes

BIO-GENE TECHNOLOGY LTD

James Joughin and Dr. Peter Beetham resign as Non-Executive Directors from Bio-Gene Technology Limited.
Dr. Beetham will join the Bio-Gene Scientific Advisory Board.
Managing Director and CEO, Richard Jagger, plans to transition from his full-time role to an ongoing consultancy and advisory role.

2023-04-24 08:57:00

BGT: Bio-Gene Extends Commercial Development Agreement

BIO-GENE TECHNOLOGY LTD

Bio-Gene Technology Limited extends its commercial development agreement with Clarke Mosquito Control, granting rights to develop and commercialize Flavocide™ for an additional mosquito control market segment in the United States and Cayman Islands.
The extension focuses on residential mosquito control services on private properties, increasing the market opportunity with Clarke by 150% to a total of US$250 million.
The extended agreement triggers a milestone payment to Bio-Gene, which will be used to support registration studies and further product development.

2023-04-13 09:01:00

BGT: Allowance of United States Patent

BIO-GENE TECHNOLOGY LTD

US Patent Office allows new patent for Bio-Gene's technology.
New patent pertains to the use of Bio-Gene molecules to control resistant pests.
Patent protection is extended until 2038 and supports Bio-Gene's value proposition.

2023-03-17 09:16:00

BGT: Bio-Gene Receives R&D Tax Incentive

BIO-GENE TECHNOLOGY LTD

Bio-Gene Technology Limited has received a $446,000 Research and Development (R&D) tax incentive from the Australian Taxation Office.
The cash incentive is for research and development costs incurred in the 2021/2022 financial year.
This rebate relates to both Australian and eligible overseas expenditure for the development of the Company’s products FlavocideTM and QcideTM.

2023-01-20 08:26:00

BGT: Bio-Gene and STK Agree Binding Terms on Global Collaboration

BIO-GENE TECHNOLOGY LTD

Bio-Gene and STK Bio-Ag Technologies agree to collaborate globally to develop, register, and commercialise QcideTM for crop protection applications.
Bio-Gene grants STK a non-exclusive licence to develop QcideTM technology for crop protection, aquaculture, turf and ornamentals markets.
STK will fund the registration of QcideTM, while Bio-Gene has full access to registrations to support other commercial opportunities.

2023-01-19 12:14:00

ASX Briefs...everything...in 3 bullet points

ASX Briefs

*Disclaimer

BIO-GENE TECHNOLOGY LTD (ASX: BGT)

BGT: GRDC Confirms Support for Flavocide in Grain Storage

BIO-GENE TECHNOLOGY LTD

BGT: Synergy Studies Offer Significant Commercial Opportunities

BIO-GENE TECHNOLOGY LTD

BGT: Board and Management Changes

BIO-GENE TECHNOLOGY LTD

BGT: Bio-Gene Extends Commercial Development Agreement

BIO-GENE TECHNOLOGY LTD

BGT: Allowance of United States Patent

BIO-GENE TECHNOLOGY LTD

BGT: Bio-Gene Receives R&D Tax Incentive

BIO-GENE TECHNOLOGY LTD

BGT: Bio-Gene and STK Agree Binding Terms on Global Collaboration

BIO-GENE TECHNOLOGY LTD